| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -14,275 | -12,497 | -11,505 | -23,121 |
| Depreciation and amortization expense | 706 | 790 | 804 | 1,658 |
| Loss on fixed asset impairment | NaN | NaN | 0 | 19 |
| Noncash interest expense | NaN | 73 | 24 | NaN |
| Amortization of debt discount and issuance costs | 86 | NaN | NaN | NaN |
| Stock-based compensation expense | 1,223 | 627 | 1,146 | 2,260 |
| Provision for excess and obsolete inventory | 0 | 695 | 7 | 441 |
| Noncash lease expense | NaN | 1,218 | NaN | NaN |
| Non-cash lease expense | -609 | NaN | 305 | 609 |
| Gain on revaluation of warrant liability | -70 | -172 | 41 | NaN |
| Accretion on investments | -131 | -57 | -145 | -149 |
| Other | -58 | -61 | 44 | -17 |
| Accounts receivable | 3,233 | -2,298 | -618 | -1,471 |
| Inventory | -144 | -3,098 | 514 | 1,119 |
| Prepaid expenses and other current assets | 318 | -61 | -77 | -182 |
| Other long-term assets | 13 | -74 | 10 | 0 |
| Accounts payable | 530 | 549 | 251 | 800 |
| Accrued expenses and other current liabilities | -2,232 | 1,097 | 599 | -1,668 |
| Other long-term liabilities | NaN | 48 | 16 | NaN |
| Deferred revenue | 1,900 | -336 | -1,065 | -463 |
| Net cash used in operating activities | -15,058 | -3,246 | -9,051 | -18,765 |
| Purchases of property and equipment | 394 | 92 | 73 | 685 |
| Purchases of investments | 3,016 | 4,021 | 20,765 | 2,290 |
| Sales of investments | 2,006 | 0 | 2,505 | NaN |
| Maturity of investments | 10,000 | 8,000 | 8,750 | 23,000 |
| Net cash provided by investing activities | 8,596 | 3,887 | -9,583 | 20,025 |
| Proceeds from issuance of class a common stock - stock option exercise | 116 | 6 | 62 | 423 |
| Proceeds from issuance of class a common stock - employee stock purchase plan | 140 | 0 | 72 | 90 |
| Proceeds from issuance of debt | NaN | 0 | 20,000 | NaN |
| Payments of debt issuance costs | NaN | 0 | 878 | NaN |
| Issuance of class a common stock under the atm offering | NaN | 445 | NaN | NaN |
| Tax withholding on settlement of restricted stock units | NaN | 0 | 1 | 418 |
| Payments on finance lease obligations | 9 | 8 | 8 | 14 |
| Net cash provided by financing activities | 247 | 443 | 19,247 | 81 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -6,215 | 1,084 | 613 | 1,341 |
| Cash, cash equivalents and restricted cash at beginning of period | 20,314 | 19,230 | 17,276 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 14,099 | 20,314 | 19,230 | NaN |
RAPID MICRO BIOSYSTEMS, INC. (RPID)
RAPID MICRO BIOSYSTEMS, INC. (RPID)